Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases Arndt-Christian MüllerDaniel M. AebersoldProstate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO) Review Article Open access 15 June 2022 Pages: 683 - 689
On the probability of lymph node negativity in pN0-staged prostate cancer—a theoretically derived rule of thumb for adjuvant needs Frank PaulsenJens BedkeArndt-Christian Müller Original Article Open access 02 September 2021 Pages: 690 - 699
Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer Salvatore CozziAndrea BottiCinzia Iotti Original Article 10 November 2021 Pages: 700 - 709
Radiomics-based prognosis classification for high-risk prostate cancer treated with radiotherapy Ciro FranzeseLuca CozziMarta Scorsetti Original Article 21 January 2022 Pages: 710 - 718
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy Matthias MollDavid D’AndreaGregor Goldner Original Article Open access 13 March 2022 Pages: 719 - 726
Radiotherapy in oligometastatic prostate cancer—a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO) Paul RogowskiChristian TrappMinglun Li Original Article Open access 01 April 2022 Pages: 727 - 734
Propensity score-matched analysis comparing dose-escalated intensity-modulated radiation therapy versus external beam radiation therapy plus high-dose-rate brachytherapy for localized prostate cancer Jörg TamihardjaIngulf LawrenzMichael Flentje Original Article Open access 12 May 2022 Pages: 735 - 743
Effect of plan complexity on the dosimetry, delivery accuracy, and interplay effect in lung VMAT SBRT with 6 MV FFF beam Chao GeHuidong WangYinghua Shi Original Article 29 April 2022 Pages: 744 - 751
Die Wahl der Chemotherapie unter einer PET-CT-geführten Therapiedeeskalation hat einen signifikanten Einfluss auf die Fertilität und Lebensqualität junger Hodgkin-Patientinnen und Patienten Ricarda Stella GuninskiPanagiotis Balermpas Literatur kommentiert 22 April 2022 Pages: 752 - 754
Phase-II-Studie zur Therapiedeeskalation bei HPV-assoziierten Oropharynxkarzinomen. Kommentar II Robert Michael HermannHans Christiansen Literatur kommentiert Open access 13 May 2022 Pages: 755 - 758
Geschichte der Hypofraktionierung und „die Tabelle an der Wand“ Thomas Brunner Literatur kommentiert 08 June 2022 Pages: 759 - 760
Schwangerschaft nach Brustkrebserkrankung: Ergebnisse eines systematischen Reviews mit Metaanalyse Rainer Souchon Literatur kommentiert 22 April 2022 Pages: 761 - 763